Skip to Main Content

hero-news

News

Category: Latest Updates

Volastra Therapeutics Co-founder Samuel Bakhoum to Deliver Plenary Presentation at American Association for Cancer Research Annual Meeting 2021

Dr. Bakhoum will present on the critical role of chromosomal instability in cancer metastasis. NEW...

Volastra Therapeutics Extends Seed Financing to $44 Million to Advance Drug Discovery Programs to Prevent Cancer Metastasis

Company founded by Polaris Partners with latest financing led by Vida Ventures Funding will support...

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research

Collaboration will integrate Microsoft Azure AI and Volastra’s insights into tumor biology to develop machine...

Volastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment

Collaboration will combine Volastra's expertise in cancer biology with Dewpoint's platform for targeting condensates to identify drug candidates that can stop metastasis and disease progression

Volastra Therapeutics Appoints Charles Hugh-Jones as Chief Executive Officer

September 16, 2020

Volastra Therapeutics Inc. has hired a chief executive with experience at Allergan PLC and other top drug companies.